| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/08/2002 | US20020107206 Treatment of acute coronary syndrome with GLP-1 |
| 08/08/2002 | US20020107205 Exposing to a matrix of type I collagen and bone morphogenic protein-4 (BMP-4) |
| 08/08/2002 | US20020107204 Protease-activated receptor-1 or 2 (PAR-1, PAR-2) |
| 08/08/2002 | US20020107203 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 08/08/2002 | US20020107202 Complementary peptides for the proline-glycine-proline sequence as antagonists of polymorphonuclear leukocyte chemoattractants; treating alkali-injuried eyes |
| 08/08/2002 | US20020107201 Analogues of peptides from a lipopolysaccharide binding protein region with given amino acid substitutions; treating sepsis |
| 08/08/2002 | US20020107200 Aqueous solution of parathyroid hormone, stabilizer such as mannitol, and buffering agent for acidic ph; shelf life |
| 08/08/2002 | US20020107199 Administering a Clostridium neurotoxin component using a needleless syringe to treat involunatary muscle contraction |
| 08/08/2002 | US20020107197 Ligands for G protein coupled receptors and methods of using them |
| 08/08/2002 | US20020107196 Thereby stimulating angiogenesis in the vasculature of the patient |
| 08/08/2002 | US20020107195 For the treatment of inflammatory diseases, angiogenic diseases, and infections, such as HIV |
| 08/08/2002 | US20020107194 Able to bind to a Notch protein forming Delta-Notch complex |
| 08/08/2002 | US20020107192 Isolated 23686 proteins, fusion proteins, antigenic peptides and anti-23686 antibodies and diagnostic methods utilizing said |
| 08/08/2002 | US20020107191 Combination drug therapy |
| 08/08/2002 | US20020107188 By injecting somatotropin, preferably in purified form, in a buffer solution, and injecting one time or multiple repeat times |
| 08/08/2002 | US20020107186 Isolated NOVX polynucleotides and polypeptides encoded by them |
| 08/08/2002 | US20020107185 Lowering the level of Insulin-like Growth Factor-I in the specific site of the body at which adhesions (scars) are unwanted using protease resistant, modified IGF Binding Protein-4 |
| 08/08/2002 | US20020107184 Method for treating melanoma |
| 08/08/2002 | US20020107183 Pharmaceutical preparations comprising cyclosporin for oral administration |
| 08/08/2002 | US20020107182 Compositions and methods for treatment of sexual dysfunction |
| 08/08/2002 | US20020107181 Novel hepatitis C virus ("HCV") protease inhibitors and pharmaceutical compositions comprising them optionally with viricide ribavirin and interferon |
| 08/08/2002 | US20020107180 Cell surface glycoproteins |
| 08/08/2002 | US20020107178 Methods and preparations for curing clinically ill patients |
| 08/08/2002 | US20020107177 And methods for identifying Factor XIIIa inhibitors by contacting chemical in question with lipoprotein(a) component, a matrix component, and Factor XIIIa; complex formation inhibition indicates activity |
| 08/08/2002 | US20020107175 Insulin c-peptides |
| 08/08/2002 | US20020107174 Microbial inhibitors or as synergistic enhancers of antibiotics and preservatives for cosmetics and other personal care preparations; endotoxin neutralizing proteins (ENPs) of horseshoe crabs |
| 08/08/2002 | US20020107170 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 08/08/2002 | US20020106796 PAX8-PPARgamma nucleic acid molecules and polypeptides and uses thereof |
| 08/08/2002 | US20020106795 Pluripotent stem cell; for use in the treatment of thalassemia and sickle cell anemia |
| 08/08/2002 | US20020106794 Purifying dopamine cells; obtain cells, transfect with vector coding fluorescent molecules, detect fluorescent cells, recover fluorscent cells |
| 08/08/2002 | US20020106791 Nutrient broth containin mitogen for use in cell propagation and wound healing |
| 08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 08/08/2002 | US20020106778 Human PTTG polypeptide and method for producing it |
| 08/08/2002 | US20020106777 Human PEC-60-like protein and DNA encoding this protein |
| 08/08/2002 | US20020106776 pth |
| 08/08/2002 | US20020106773 Protein-protein interactions in neurodegenerative diseases |
| 08/08/2002 | US20020106771 Nucleic acids encoding CLK protein kinases |
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof |
| 08/08/2002 | US20020106742 Nucleic acids encoding active and inactive CCR5 chemokine receptors |
| 08/08/2002 | US20020106741 Nucleotide sequences coding membrane protein for use in the treatment of psychological and nervous system disorders |
| 08/08/2002 | US20020106738 Novel Siglec gene |
| 08/08/2002 | US20020106737 Polypeptide for use in the diagnosis, prevention and treatment of cancer, cellular differentiation, immunological and coagulation defects; wound healing agents |
| 08/08/2002 | US20020106736 Nucleotide sequences coding membrane protein for use in the treatment of autoimmune, rheumatoid disease, dibates, multiple sclerosis, Sjogren's syndome, glomerulonephritis and myasthenia gravis |
| 08/08/2002 | US20020106735 Novel Bcl-2 related proline rich protein (BPR) |
| 08/08/2002 | US20020106734 Adrenergic receptor |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106724 RNA-binding protein |
| 08/08/2002 | US20020106713 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule |
| 08/08/2002 | US20020106689 Detecting immunological defects in mammal; obtain sample tissue from mammal, detect proteasome activity, reduction in proteasome activty indicates immunological defect |
| 08/08/2002 | US20020106671 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106647 Nucleotide sequences for use in the treatment of antherosclerosis, autoimmune and inflammatory disorders |
| 08/08/2002 | US20020106645 Detecting preferential psychological disorders; obtain tissue sample, detect sequences polymorphism, presence of polymorphism indicates psychological disorders |
| 08/08/2002 | US20020106640 Peptide for use in the treatment and prevention of viral infection |
| 08/08/2002 | US20020106639 Postweaning multisystemic wasting syndrome virus from pigs |
| 08/08/2002 | US20020106631 Recombinant, active caspases and uses thereof |
| 08/08/2002 | US20020106411 Mixing water-insoluble particle and a carrier; applying to area of a lumen or other body region in need of closure |
| 08/08/2002 | US20020106404 Compounds that inhibit caspase activity for treating glaucoma |
| 08/08/2002 | US20020106403 Dispersible phospholipid stabilized microparticles |
| 08/08/2002 | US20020106374 Compositions and methods for inhibition of HIV-1 infection |
| 08/08/2002 | US20020106372 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106370 Improvements in or relating to peptide delivery |
| 08/08/2002 | US20020106366 Composition and method for reducing gastro-intestinal distress due to alpha-D-galactoside-linked/containing sugars |
| 08/08/2002 | US20020106365 For therapy of diseases which can be treated or alleviated by a stimulation of the production of cytokines, particularly of IL-12 |
| 08/08/2002 | US20020106364 Calcium independent cytosolic phospholipase A2/B enzymes |
| 08/08/2002 | US20020106362 Method for the treatment of chemonucleolysis |
| 08/08/2002 | US20020106359 Method and composition for treating prostate cancer |
| 08/08/2002 | US20020106358 Synthetic mammalian sulphamidase and genetic sequences encoding same |
| 08/08/2002 | US20020106356 Secreted proteins |
| 08/08/2002 | US20020106355 Novel regulatory sequences of the MCP-1 gene |
| 08/08/2002 | US20020106350 Methods for therapy of neurodegenerative disease of the brain |
| 08/08/2002 | US20020106347 Cytokines and their use in treatment and/or prophylaxis of breast cancer |
| 08/08/2002 | US20020106339 Compositions and methods using direct MMP inhibitors for inhibiting photoaging of skin |
| 08/08/2002 | US20020106333 Enamel matrix related polypeptide |
| 08/08/2002 | US20020106331 Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols |
| 08/08/2002 | US20020106323 Natural killer cell enhancing factor C |
| 08/08/2002 | DE10105039A1 Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten Tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/08/2002 | DE10104362A1 Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit Crystal modification of a cyclic depsipeptide with better efficacy |
| 08/08/2002 | CA2472051A1 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep) |
| 08/08/2002 | CA2444661A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | CA2437555A1 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | CA2437194A1 Methods for regulating the kinase domain of ephb2 |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436773A1 Human protein kinase n-like polypeptide and uses thereof |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436748A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | CA2436610A1 Protein kinase signalling |
| 08/08/2002 | CA2436576A1 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | CA2436425A1 Hypoglycemic agent |
| 08/08/2002 | CA2436418A1 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2436266A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | CA2436088A1 Two splice variants of the human pftaire serine/threonine kinase |